Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees

• Status: Terminated
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test how tolerable and effective acamprosate is when used to prevent alcohol relapse in criminal justice supervisees (those on probation, parole, or in drug court).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Virginia Commonwealth University
• Collaborator: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
• Treatments: Acamprosate; Ethanol

Criteria

Inclusion Criteria:

• History of alcohol dependence in the year before entering criminal justice supervision

• Currently under criminal justice supervision (drug court, probation, or parole) in central Virginia

Exclusion Criteria:

• Pregnant or nursing a baby

• Known sensitivity to acamprosate

• Elevated serum creatinine level or other evidence of kidney problems

• Symptoms of severe depression or suicidal ideation

• Non-English speaking such that they cannot provide informed consent

• Cognitive impairment such that they cannot provide informed consent